My Cart [ 0 ]
Home > Chemicals > Inhibitors, Activators, Antagonists, and Agonists > A-Z Inhibitors, Activators, Antagonists, and Agonists > MGCD0103

MGCD0103

Mocetinostat

Catalog No. Product Name Size List Price (US$) Quantity
APIM050338 MGCD0103 25 mg 98.00
APIM050338 MGCD0103 100 mg 280.00
APIM050338 MGCD0103 200 mg 450.00
Description

Background Information:

MGCD0103 is a rationally designed, oral, isotype-selective, small molecule HDAC inhibitor, selectively targeting HDACs 1, 2, 3 and 11 with IC50s at low micromolars. MGCD0103 displays promising antitumor activity in hematological and lymphoproliferative diseases, currently in clinical trials.

Reference:

1. Reisman, David. Polymorphisms in BRM gene associated with cancer cells and methods for diagnosis and drug screening for antitumor agents. U.S. Pat. Appl. Publ. (2010), 59pp., Cont.-in-part of U.S. Ser. No. 365,268. CODEN: USXXCO US 2010087328 A1 20100408 CAN 152:446756 AN 2010:442057.
2. Bradner, James E.; West, Nathan; Grachan, Melissa L.; Greenberg, Edward F.; Haggarty, Stephen J.; Warnow, Tandy; Mazitschek, Ralph. Chemical phylogenetics of histone deacetylases. Nature Chemical Biology (2010), 6(3), 238-243.
3. Reisman, David. BRM expression in cancer cells and related diagnostics and treatment. PCT Int. Appl. (2010), 87pp. CODEN: PIXXD2 WO 2010014582 A2 20100204 CAN 152:231205 AN 2010:146930.

APIM050338: MGCD0103

CAS No.: 726169-73-9.
Molecular Formula: C23H20N6O.
Molecular Weight: 396.4.
Purity: >99.5% (by HPLC).
QC: HPLC, 1HNMR, and Quantitative Elemental Analysis.
Solubility: Soluble in DMSO.
Storage: Store at 0°C (short term), -20°C (long term), desiccated.

Related Links

See our Privacy Policy